Healthcare Sector: Identifying Future Leaders
Names rising to the top of the screen
The strongest names remain easy to scan without losing the valuation context behind the ranking.
| # | Ticker | Company | AI Score | Price | Change | Market Cap | P/E |
|---|---|---|---|---|---|---|---|
| 1 | EXEL | Exelixis, Inc. | 98 | $57.61 | -1.24% | $14.4B | 17.5 |
| 2 | INCY | Incyte Corporation | 98 | $123.28 | -2.17% | $25.0B | 15.2 |
| 3 | KRYS | Krystal Biotech, Inc. | 98 | $345.55 | -0.73% | $10.2B | 41.8 |
| 4 | UTHR | United Therapeutics Corporation | 97 | $503.86 | -0.58% | $21.4B | 16.7 |
| 5 | HRMY | Harmony Biosciences Holdings, Inc. | 97 | $41.10 | -1.25% | $2.4B | 13.1 |
| 6 | INSP | Inspire Medical Systems, Inc. | 97 | $68.12 | +2.47% | $2.0B | 14.6 |
| 7 | ARGX | argenx SE | 97 | $984.04 | -1.82% | $61.2B | 36.0 |
| 8 | ETON | Eton Pharmaceuticals, Inc. | 97 | $57.15 | -1.26% | $1.6B | 124.5 |
| 9 | NHC | National HealthCare Corporation | 97 | $224.92 | -1.02% | $2.2B | — |
| 10 | BLLN | BillionToOne, Inc. | 96 | $98.51 | -0.66% | $4.5B | 142.7 |
| 11 | HALO | Halozyme Therapeutics, Inc. | 96 | $107.00 | -0.36% | $12.7B | 30.4 |
| 12 | LQDA | Liquidia Corporation | 96 | $67.97 | -1.66% | $6.0B | 43.2 |
Where valuation pressure is clustering
Shortlist Context
“MoonshotScore rates a US-listed stock 0 to 100 — higher means stronger numbers. Most carry an older nine-factor score; the rest use five sector-relative pillars, re-ranked daily — common stocks and ADRs only. Funds, ETFs, warrants, units, SPACs, preferreds, and notes carry none. It is built for education and deeper due diligence, not financial advice.”
Questions worth resolving before acting on the screen
What makes healthcare stocks attractive for investment in 2026?
The healthcare sector benefits from consistent demand, driven by an aging population and technological advancements, leading to stable revenue streams and growth opportunities.
What criteria are used to select the best healthcare stocks?
The selection process focuses on revenue growth, strength of product pipeline, market share, financial health, and strategic adaptation to market dynamics.
How do regulatory changes and technological advancements impact the healthcare sector?
Regulatory changes can create both challenges and opportunities, while technological advancements drive innovation and efficiency, impacting company growth and market positioning.
What are the primary risks associated with investing in healthcare stocks?
Risks include regulatory hurdles, patent expirations, competition from generics, and the high costs associated with research and development.
How does demographic change influence the healthcare market?
An aging global population increases the demand for healthcare services and pharmaceuticals, creating opportunities for companies in these sectors.